Features

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Marcolin and Abercrombie & Fitch Co. Enter an Exclusive Licensing Agreement

This partnership covers the design, production, and distribution of Abercrombie, abercrombie kids and Hollister brand eyewear, including sunglasses and optical frames.

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

1 14 15 16 17 18 469

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Marcolin and Abercrombie & Fitch Co. Enter an Exclusive Licensing Agreement

This partnership covers the design, production, and distribution of Abercrombie, abercrombie kids and Hollister brand eyewear, including sunglasses and optical frames.

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

1 14 15 16 17 18 469

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Marcolin and Abercrombie & Fitch Co. Enter an Exclusive Licensing Agreement

This partnership covers the design, production, and distribution of Abercrombie, abercrombie kids and Hollister brand eyewear, including sunglasses and optical frames.

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

1 14 15 16 17 18 469

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Marcolin and Abercrombie & Fitch Co. Enter an Exclusive Licensing Agreement

This partnership covers the design, production, and distribution of Abercrombie, abercrombie kids and Hollister brand eyewear, including sunglasses and optical frames.

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

1 14 15 16 17 18 469